A NEW PARADIGM IN SMALL-MOLECULE DRUG DISCOVERY



Novation Pharmaceuticals is using a new approach, modulation of intracellular messenger RNA (mRNA), to identify new small-molecule therapies to treat serious diseases. Novation's technology, called QUEST, is a breakthrough in identifying new, orally active small molecule drugs for significant therapeutic targets.

Novation is seeking to build a product focused business based on modulation of mRNA. Priority is to discover its own products using QUEST, whilst generating early revenues through strategic partnerships with pharmaceutical companies.

Novation's QUEST technology -- taking drug discovery to a new level